Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01862718 · ClinicalTrials.gov registry record · Phase 1

Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms

A Phase 1 study, sponsored by National Institutes of Health Clinical Center (CC).

Terminated
Registry status
Phase 1
Development phase
5
Enrollment target

NCT01862718: Clinical Trial Phase 1 study, sponsored by National Institutes of Health Clinical Center (CC).

NCT01862718 is a Phase 1 study that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01862718, a Phase 1 study, was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).

TERMINATED
Registry status
Phase 1
Development phase
5 participants
Enrollment target

Study Summary

Background: Pilot study to assess feasibility for combining treatment modalities that should be synergistic (radiation and thermal ablation). Thermal ablation with Radiofrequency Ablation (RFA) and microwave ablation (MWA) are standard treatments for focal neoplasms in the liver. High volume or scattered locations of tumor burden results in inability to successfully use this technology for a large proportion of patients with hepatic neoplasms. Methods to enhance treatment volumes could be advantageous in potentially increasing the indications for thermal ablation or the number of patients benefitting from local ablation. Primary objective: To determine the safety of combining 2 standard therapies (thermal ablation and external beam radiation therapy) for liver neoplasms up to 10 cm diameter. Eligibility: Patients greater than 18 years of age with pathologically proven unresectable primary or metastatic hepatic neoplasms Patients whose extent of hepatic metastases represents approximately less than 60% of total liver volume AND whose extrahepatic metastatic disease is determined to be minimal ECOG performance status of less than or equal to 2 and a life expectancy of more than 3 months Patients with a history of chemotherapy, radiation therapy, or biological therapy for at least 4 weeks prior to starting study treatments, and 4 weeks after treatments Patients must not have an acute, critical illness If clinical or imaging evidence for cirrhosis present, then Bilirubin must be less than 3 mg/dl and Child-Pugh Classification A, (Class B \& C are excluded) Design: Patients will undergo external beam radiation as well as thermal ablation according to standard operating procedures of the NCI and NIH CC. Patients will be monitored using the standard imaging studies when clinically warranted. Patients may be treated with a second (or more) thermal ablation procedure ALONE if it is deemed beneficial for the patient by the investigator. The sample size will b

Primary Outcome

Descriptive statistics will be provided in summary tables. When relevant, the 95% confidence intervals (CI) will also be displayed.

Interventions

  • PROCEDURE Thermal Ablation
  • PROCEDURE Standard External Beam Radiation Therapy

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2013-11-19
Est. Completion 2019-11-05
Phase Phase 1

Why NCT01862718 stopped before completion

NCT01862718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Thermal Ablation is the first listed.

NCT01862718 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01862718 about?

NCT01862718 is a clinical study titled "Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms". Background: Pilot study to assess feasibility for combining treatment modalities that should be synergistic (radiation and thermal ablation). Thermal ablation with Radiofrequency Ablation (RFA) and microwave ablation (MWA) are standard treatments for focal neoplasms in the liver. High volume or s...

What is the current status of trial NCT01862718?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2013-11-19. Estimated completion is 2019-11-05.

What interventions are being tested in trial NCT01862718?

The interventions under investigation include: Thermal Ablation (PROCEDURE), Standard External Beam Radiation Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT01862718?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01862718's enrollment target sits among peer trials

5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01862718, the US trial registry maintained by the National Library of Medicine. NCT01862718 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.